俵　修一教授

博士(医学)

https://researchmap.jp/stvet633/

創薬科学、トランスレーショナルリサーチ

基礎研究の実用化への橋渡し

抗微生物薬の創薬研究

薬剤耐性とワンヘルス

1. 俵修一, 榑林陽一　（2015）　特集 「医薬品開発における産官学連携の展望」　１．総論 ３）行政の立場から ～わが国の医薬品開発における 「創薬支援ネットワーク」の役割～　医薬ジャーナル, 51(10), 69-74
2.  Tawara, S., Ikeda, F., Maki, K., Morishita, Y., Otomo, K., Teratani, N., Goto, T., Tomishima, M., Ohki, H., Yamada, A., Kawabata, K., Takasugi, H., Sakane, K., Tanaka, H., Matsumoto, F., Kuwahara, S. (2000) In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrobial Agents and Chemotherapy, 44(1), 57-62
3. Ikeda, F., Wakai, Y., Matsumoto, S., Maki, K., Watabe, E., Tawara, S., Goto, T., Watanabe, Y., Matsumoto, F., Kuwahara, S. (2000) Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrobial Agents and Chemotherapy, 44(3), 614-618
4.  Mine, Y., Watanabe, Y., Sakamoto, H., Hatano, K., Kuno, K., Kamimura, T., Tawara, S., Matsumoto, Y., Matsumoto, F., Kuwahara, S. (1993) Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. Journal of Antibiotics, 46(1), 99-119
5.  Mine, Y., Kamimura, T., Watanabe, Y., Tawara, S., Matsumoto, Y., Shibayama, F., Kikuchi, H., Takaya, T., Kuwahara, S. (1988) In vitro antibacterial activity of FK482, a new orally active cephalosporin. Journal of Antibiotics, 41(12), 1873-87